Healthcare provider profile · identity verified

Justin Quinlan, DO

Family Practice · SPRINGFIELD, MA · NPI 1124558481

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	364	115
Lisinopril	Lisinopril	298	85
Levothyroxine Sodium	Levothyroxine Sodium	271	75
Amlodipine Besylate	Amlodipine Besylate	270	85
Oxycodone Hcl	Oxycodone Hcl	228	27
Gabapentin	Gabapentin	224	49
Omeprazole	Omeprazole	220	58
Losartan Potassium	Losartan Potassium	191	58
Hydrochlorothiazide	Hydrochlorothiazide	179	49
Metoprolol Succinate	Metoprolol Succinate	148	47
Lorazepam	Lorazepam	140	38
Sertraline Hcl	Sertraline Hcl	112	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	107	15
Pravastatin Sodium	Pravastatin Sodium	100	30
Clonazepam	Clonazepam	81	14
Morphine Sulfate Er	Morphine Sulfate	72	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	71	20
Fluticasone Propionate	Fluticasone Propionate	70	27
Rosuvastatin Calcium	Rosuvastatin Calcium	68	20
Albuterol Sulfate Hfa	Albuterol Sulfate	64	34
Trazodone Hcl	Trazodone Hcl	62	20
Morphine Sulfate	Morphine Sulfate	60	suppressed
Bupropion Xl	Bupropion Hcl	58	16
Metoprolol Tartrate	Metoprolol Tartrate	58	12
Furosemide	Furosemide	56	20
Atenolol	Atenolol	54	14
Escitalopram Oxalate	Escitalopram Oxalate	54	20
Eliquis	Apixaban	52	13
Famotidine	Famotidine	52	16
Simvastatin	Simvastatin	52	14
Tramadol Hcl	Tramadol Hcl	52	11
Metformin Hcl Er	Metformin Hcl	50	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	18
Citalopram Hbr	Citalopram Hydrobromide	42	13
Pantoprazole Sodium	Pantoprazole Sodium	42	16
Allopurinol	Allopurinol	41	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	41	17
Pregabalin	Pregabalin	40	suppressed
Duloxetine Hcl	Duloxetine Hcl	38	12
Valacyclovir	Valacyclovir Hcl	38	14
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Ventolin Hfa	Albuterol Sulfate	36	suppressed
Montelukast Sodium	Montelukast Sodium	35	11
Topiramate	Topiramate	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Carvedilol	Carvedilol	34	suppressed
Irbesartan	Irbesartan	34	suppressed
Meloxicam	Meloxicam	34	suppressed
Prednisone	Prednisone	33	17
Chlorthalidone	Chlorthalidone	32	12
Jardiance	Empagliflozin	32	suppressed
Baclofen	Baclofen	29	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Xarelto	Rivaroxaban	26	suppressed
Nystatin	Nystatin	25	13
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	11
Alendronate Sodium	Alendronate Sodium	24	suppressed
Metformin Hcl	Metformin Hcl	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	18
Triamcinolone Acetonide	Triamcinolone Acetonide	22	15
Arnuity Ellipta	Fluticasone Furoate	21	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Lidocaine	Lidocaine	20	suppressed
Colchicine	Colchicine	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Temazepam	Temazepam	17	suppressed
Valsartan	Valsartan	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Finasteride	Finasteride	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Ozempic	Semaglutide	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error